Response of primary tumor and lymph node in non-small cell lung cancer after neoadjuvant immunotherapy: a pooled analysis

The good pathological response of primary tumors (PTs) to neoadjuvant immunotherapy has been acknowledged in non-small cell lung cancer (NSCLC), however, it remains unclear whether neoadjuvant immunotherapy shows consistent effects in metastatic lymph nodes (LNs). We compared the pathological respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhai, Wen-Yu, Zhao, Ze-Rui, Chen, Si, Yu, Hui, Lin, Yao-Bin, Wang, Yi-Zhi, Long, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478833/
https://www.ncbi.nlm.nih.gov/pubmed/36109085
http://dx.doi.org/10.1136/jitc-2022-005160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478833/
https://www.ncbi.nlm.nih.gov/pubmed/36109085
http://dx.doi.org/10.1136/jitc-2022-005160

Ejemplares similares